SA
SUN ANTHONY Y Chief Executive Officer
C-suite M
US US · SEC (Form 4)
Discover the full record of transactions filed by SUN ANTHONY Y, Chief Executive Officer. Director active across 2 companies, notably Zentalis Pharmaceuticals, Inc.. Aggregated, 29 filings have been recorded. Total volume traded: €9.3m. The latest transaction was disclosed on 4 April 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations 29 total
€462,691 10,471 shares @ €44.1879 0.16% mcap 5.0% of flow
Common Stock
SEC:0001725160-22-000068:0 · 4 Apr 2022
€388,999 8,771 shares @ €44.3505 0.13% mcap 4.2% of flow
Common Stock
SEC:0001725160-22-000055:0 · 1 Mar 2022
050,431 shares 0
Common Stock
SEC:0001725160-22-000031:0 · 10 Feb 2022
€208,629 4,124 shares @ €50.5889 0.072% mcap 4.9% of flow
Common Stock
SEC:0001725160-22-000017 · 1 Feb 2022
€208,629 4,124 shares @ €50.5889 0.072% mcap 2.2% of flow
Common Stock
SEC:0001725160-22-000017:0 · 1 Feb 2022
015,000 shares 0
Common Stock
SEC:0001725160-22-000006 · 16 Dec 2021
015,000 shares 0
Common Stock
SEC:0001725160-22-000006:0 · 16 Dec 2021
0125,000 shares 0
Common Stock
SEC:0001725160-21-000236 · 26 Nov 2021
0125,000 shares 0
Common Stock
SEC:0001725160-21-000236:0 · 26 Nov 2021
0125,000 shares 0
Common Stock
SEC:0001725160-21-000232 · 26 Nov 2021
0125,000 shares 0
Common Stock
SEC:0001725160-21-000232:0 · 26 Nov 2021
06,963 shares 0
Common Stock, par value $.0001
SEC:0001415889-21-005363 · 17 Nov 2021
06,963 shares 0
Common Stock, par value $.0001
SEC:0001415889-21-005363:0 · 17 Nov 2021
€308,735 4,420 shares @ €69.8496 0.11% mcap 7.3% of flow
Common Stock
SEC:0001725160-21-000211 · 1 Nov 2021
€308,735 4,420 shares @ €69.8496 0.11% mcap 3.3% of flow
Common Stock
SEC:0001725160-21-000211:0 · 1 Nov 2021
€594,000 10,464 shares @ €56.7661 0.21% mcap 14.0% of flow
Common Stock
SEC:0001725160-21-000198 · 4 Oct 2021
€594,000 10,464 shares @ €56.7661 0.21% mcap 6.4% of flow
Common Stock
SEC:0001725160-21-000198:0 · 4 Oct 2021
€707,552 12,487 shares @ €56.6631 0.25% mcap 16.7% of flow
Common Stock
SEC:0001725160-21-000190 · 1 Sept 2021
€707,552 12,487 shares @ €56.6631 0.25% mcap 7.6% of flow
Common Stock
SEC:0001725160-21-000190:0 · 1 Sept 2021
€290,595 6,900 shares @ €42.1153 0.10% mcap 6.9% of flow
Common Stock
SEC:0001725160-21-000176 · 2 Aug 2021
€290,595 6,900 shares @ €42.1153 0.10% mcap 3.1% of flow
Common Stock
SEC:0001725160-21-000176:0 · 2 Aug 2021
€765,485 19,348 shares @ €39.564 0.27% mcap 18.1% of flow
Common Stock
SEC:0001725160-21-000170 · 6 Jul 2021
€765,485 19,348 shares @ €39.564 0.27% mcap 8.2% of flow
Common Stock
SEC:0001725160-21-000170:0 · 6 Jul 2021
€311,249 7,349 shares @ €42.3525 0.11% mcap 7.3% of flow
Common Stock
SEC:0001725160-21-000162 · 1 Jul 2021
€311,249 7,349 shares @ €42.3525 0.11% mcap 3.3% of flow
Common Stock
SEC:0001725160-21-000162:0 · 1 Jul 2021
25 of 29 declarations
Load more (4 remaining) About SUN ANTHONY Y Anthony Y Sun is an executive at Zentalis Pharmaceuticals, Inc.